Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain

Press releases
Team Sant Joan de Deu

EIC Accelerator

 

EIC Accelerator 2022

December 23, 2022/by noticias
Tags: EICaccelerator, funding
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/12/Sant-Joan-de-Deu-Pediatric-Hospital.jpg 768 1024 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-12-23 09:04:142022-12-23 09:14:42Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain
You might also like
Press clippingg2bPress-Clipping – Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain
Gate2Brain among the 5 Catalan startups that have obtained funding from EIC AcceleratorcanvaGate2Brain among the 5 Catalan startups that have obtained funding from EIC Accelerator

CATEGORIES

  • Clipping
  • Events
  • Media
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • StartUBUniversitat de BarcelonaStartUB dayMay 24, 2023 - 08:57
  • Tides 2023G2BTides USA 2023 Oligonucleotide & Peptide TherapeuticMay 16, 2023 - 16:50
  • Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production ModelsApril 21, 2023 - 09:10
  • https://www.lsxleaders.com/lsx-world-congressG2BG2B at LSX World Congress 2023April 18, 2023 - 07:30
  • CataloniaBio & Health Teach GalaG2BCataloniaBio HT Gala 2023March 29, 2023 - 12:00

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • HIGHLIGHTS: New CAR-T, investment rounds, capital movements and advances in oncology and Alzheimer May 25, 2023 biocat
  • The 4th edition of the e-Health Investment Forum dedicated to clinical decision making May 25, 2023 biocat
  • Open call for the 6th edition of the CRAASH Barcelona program May 24, 2023 biocat
  • Montserrat Daban, new President of Council of European BioRegions (CEBR) May 24, 2023 biocat
  • Successful 2nd edition of the “Fast-track to Barcelona-Catalonia Life Science Hub” program focused on advanced therapies May 24, 2023 biocat
  • The new investment platform in the BioRegion May 5, 2023 biocat
  • Funding breakfast, lead-up to BIOSPAIN Barcelona April 27, 2023 biocat
  • 45 companies and organisations from the BioRegion to participate in BIO Boston 2023 convention April 26, 2023 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
THIS IS HOW A DRUG IS TOWED TO THE BRAINTHIS IS HOW A DRUG IS TOWED TO THE BRAINExpansióntalento científicotalento cientificoFounding a company in times of pandemic
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}